UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells

PloS one, 2010-11, Vol.5 (11), p.e13989

2010

Link zum Volltext

Verfügbarkeit prüfen

Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model

Viruses, 2019-09, Vol.11 (9), p.819

2019

Link zum Volltext

Verfügbarkeit prüfen

Heparan Sulfate Proteoglycan Binding by Herpes Simplex Virus Type 1 Glycoproteins B and C, Which Differ in Their Contributions to Virus Attachment, Penetration, and Cell-to-Cell Spread

Journal of Virology, 1998-07, Vol.72 (7), p.6119-6130

1998

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide

Antimicrobial Agents and Chemotherapy, 2008-09, Vol.52 (9), p.3078-3084

2008

Link zum Volltext

Verfügbarkeit prüfen

Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide

Gene therapy, 2004-07, Vol.11 (13), p.1087-1098

2004

Link zum Volltext

Verfügbarkeit prüfen

HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy

Current gene therapy, 2005-10, Vol.5 (5), p.445

2005

Link zum Volltext

Verfügbarkeit prüfen

HSV as a vector in vaccine development and gene therapy

Human vaccines, 2008-03, Vol.4 (2), p.91-105

2008

Link zum Volltext

Verfügbarkeit prüfen

Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: A preliminary study as possible vaccine against genital herpes

International journal of pharmaceutics, 2013-01, Vol.440 (2), p.229-237

2013

Link zum Volltext

Verfügbarkeit prüfen

Herpes Simplex Virus Type 1 Glycoprotein B Requires a Cysteine Residue at Position 633 for Folding, Processing, and Incorporation into Mature Infectious Virus Particles

Journal of Virology, 1998-06, Vol.72 (6), p.4940-4949

1998

Link zum Volltext

Verfügbarkeit prüfen

Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer

Liver international, 2011-11, Vol.31 (10), p.1542-1553

2011

Link zum Volltext

Verfügbarkeit prüfen

HSV Recombinant Vectors for Gene Therapy~!2009-12-17~!2010-13-31~!2010-06-17

The open virology journal, 2010-08, Vol.4 (3), p.123-156

2010

Link zum Volltext

Verfügbarkeit prüfen

HSV Recombinant Vectors for Gene Therapy

The open virology journal, 2010-06, Vol.4 (1), p.123-156

2010

Link zum Volltext

Verfügbarkeit prüfen

HSV as a vector in vaccine development and gene therapy

Advances in experimental medicine and biology, 2009, Vol.655, p.118

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapeutic activity of a recombinant combined gB–gD–gE vaccine against recurrent HSV-2 infections in a guinea pig model

Vaccine, 2005-01, Vol.23 (7), p.865-872

2005

Link zum Volltext

Verfügbarkeit prüfen

Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection

Vaccine, 2000-12, Vol.19 (9), p.1225-1231

2000

Link zum Volltext

Verfügbarkeit prüfen

Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: protection studies against lethal viral infection in mice

Journal of general virology, 1995-12, Vol.76 (12), p.3137-3143

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(15)
Buchkapitel
(1)

Sprache

Englisch
(16)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells

Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model

Heparan Sulfate Proteoglycan Binding by Herpes Simplex Virus Type 1 Glycoproteins B and C, Which Differ in Their Contributions to Virus Attachment, Penetration, and Cell-to-Cell Spread

Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide

Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide

HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy

HSV as a vector in vaccine development and gene therapy

Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: A preliminary study as possible vaccine against genital herpes

Herpes Simplex Virus Type 1 Glycoprotein B Requires a Cysteine Residue at Position 633 for Folding, Processing, and Incorporation into Mature Infectious Virus Particles

Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer

HSV Recombinant Vectors for Gene Therapy~!2009-12-17~!2010-13-31~!2010-06-17

HSV Recombinant Vectors for Gene Therapy

HSV as a vector in vaccine development and gene therapy

Immunotherapeutic activity of a recombinant combined gB–gD–gE vaccine against recurrent HSV-2 infections in a guinea pig model

Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection

Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: protection studies against lethal viral infection in mice

Suchergebnisse filtern